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Mutations in the cellular retinaldehyde–binding protein (CRALBP, encoded by RLBP1) can lead to severe cone photoreceptor–
mediated vision loss in patients. It is not known how CRALBP supports cone function or how altered CRALBP leads to
cone dysfunction. Here, we determined that deletion of Rlbp1 in mice impairs the retinal visual cycle. Mice lacking CRALBP
exhibited M-opsin mislocalization, M-cone loss, and impaired cone-driven visual behavior and light responses. Additionally,
M-cone dark adaptation was largely suppressed in CRALBP-deficient animals. While rearing CRALBP-deficient mice in the
dark prevented the deterioration of cone function, it did not rescue cone dark adaptation. Adeno-associated virus–mediated
restoration of CRALBP expression specifically in Müller cells, but not retinal pigment epithelial (RPE) cells, rescued the
retinal visual cycle and M-cone sensitivity in knockout mice. Our results identify Müller cell CRALBP as a key component
of the retinal visual cycle and demonstrate that this pathway is important for maintaining normal cone–driven vision and
accelerating cone dark adaptation.

Introduction

Photoactivation of a visual pigment molecule in vertebrate rod
and cone photoreceptors rapidly triggers a light response and concomitantly renders the activated pigment unable to detect a subsequent photon of light. Regeneration of the visual pigment back
to the ground state requires recycling of its chromophore from
the “bleached” all-trans retinal to the light-sensitive 11-cis retinal.
This process, known as the visual cycle, requires export of the alltrans chromophore out of the photoreceptors and its conversion to
the 11-cis form in retinal pigment epithelial (RPE) cells (for both
rods and cones) or in retinal Müller glia (for cones only). The 11-cis
chromophore is then imported back into photoreceptors, where
it combines with a molecule of free opsin to regenerate the visual
pigment (1, 2). The cone-specific visual cycle (3) has been suggested to enable cones, but not rods, to quickly recover from bright
light exposure and to function over a wide range of light intensities
(4–6). While an active area of research (7, 8), to date, none of the
putative molecular components in this pathway have been shown
to actually affect mammalian cone function, casting doubt on the
significance of this pathway.
Cellular retinaldehyde–binding protein (CRALBP) is a retinoid-binding protein expressed in RPE and Müller glia and believed
to be involved in the retinal visual cycle (1). CRALBP is a 36-kDa
water-soluble protein with 2 conformational states facilitating
the intracellular transport of hydrophobic 11-cis retinoids (9). In
zebrafish, 2 distinct orthologs, cralbp a and cralbp b, are expressed
in RPE and Müller cells, respectively (10, 11). Notably, knockdown
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of either of the 2 isoforms leads to decreased cone-driven electroretinographic (ERG) responses (10), suggesting a role of Müller
cell–expressed CRALBP in zebrafish cone function (see also ref.
12). In mammals, CRALBP is encoded by a single gene, Rlbp1,
expressed in both RPE and Müller cells. Mutations in human
RLBP1 cause several autosomal recessive retinal diseases, such
as autosomal recessive retinitis pigmentosa (13), Bothnia dystrophy (14–16), retinitis punctata albescens (17), fundus albipunctatus (18, 19), and Newfoundland rod-cone dystrophy (20). These
visual disorders are characterized by early-onset night blindness
and may be followed by functional defects in the macular region
(21). CRALBP is required for the proper function of the RPE visual
cycle and for the timely recovery of mammalian rod and cone
ERG responses (22). However, the role of Müller cell–expressed
CRALBP in the mammalian retinal visual cycle is unknown. It is
also not clear whether CRALBP in RPE, Müller cells, or both is
required for the normal function of mammalian cones. Here, we
used behavioral and electrophysiological assays in Rlbp1–/– mice to
examine the overall effect of CRALBP deletion on M-cone function. We also used molecular tools to explore the mechanism by
which the lack of CRALBP causes cone function deterioration.
We then used adeno-associated virus–mediated (AAV-mediated)
gene transfer to selectively restore CRALBP in RPE or Müller cells
and examine the distinct roles of the 2 visual cycles in supporting
mammalian M-cone function.

Results

The deletion of CRALBP suppresses mammalian cone visual function. In addition to causing well-documented rod-driven scotopic
visual disorders (15, 17), mutations in CRALBP also disrupt conedriven photopic vision in humans (13, 16, 20). It is believed that
jci.org   Volume 125   Number 2   February 2015

727

Downloaded from http://www.jci.org on April 25, 2016. http://dx.doi.org/10.1172/JCI79651

Research article

The Journal of Clinical Investigation  

Figure 1. Deletion of CRALBP reduces photopic in vivo ERG–response amplitude and sensitivity. (A) Representative in vivo cone ERG responses from
control (black traces), Rlbp1–/– (red traces), and Rlbp1+/– (blue traces) mice. Test flash intensities increased from 2.27 × 10–2 cd × s/m2 (bottom traces) to 697
cd × s/m2 (top traces) in steps of approximately 0.5 log units. (B) Ensemble-averaged cone b-wave intensity-response curves for control (n = 10), Rlbp1–/–
(n = 12), and Rlbp1+/– (n = 10) mice. (C) Cone b-wave intensity-response curves for control mice aged 6–7 weeks (black squares, n = 8) and 13–16 weeks (white
squares, n = 10). (D) Cone b-wave intensity-response curves for Rlbp1–/– mice aged 6–7 weeks (red circles, n = 6) and 13–16 weeks (white circles, n = 6). Insets
in B–D show the corresponding normalized (r/rmax) intensity-response curves. Results represent the mean ± SEM.

the pathophysiology for both rods and cones is based on inefficient
chromophore recycling (13, 14). However, the exact mechanisms
of cone dysfunction in CRALBP-related diseases and the relative
contributions of the RPE visual cycle and the retinal visual cycle
to cone dark adaptation are unknown. To address these questions,
we first examined how the deletion of CRALBP affects the conedriven photopic visual performance of CRALBP-knockout mice by
optomotor response behavioral tests. All functional experiments
were performed with knockout mice lacking the rod transducin α
subunit (Gnat1–/–). This facilitated the isolation of cone function
by ablating rod photoresponses while preserving normal retina
morphology and cone function (6, 23). The experiments were performed with LCD monitor white light, which would be expected to
selectively activate mouse M-cones (peak absorption at 508 nm)
but not S-cones (peak absorption at 360 nm) (24). We found that
the background light intensity required to achieve half-maximal
cone-driven contrast sensitivity in 6-week-old Rlbp1–/– mice was
approximately 10-fold higher than that required for controls (–0.4
and –1.3 log cd × s/m2, respectively). Thus, the absence of CRALBP
caused a substantial desensitization of cone-driven vision.
We then asked whether the vision loss observed at a behavioral level was caused by the deterioration of cone function in the
absence of CRALBP. We conducted in vivo ERG recordings to
examine the dark-adapted cone b-wave responses of 6- to 13-weekold Rlbp1–/– mice. We used 530-nm LED flashes to selectively excite
M-cones (24) up to the system’s 25 cd × s/m2 intensity limit and
Xenon flash for higher intensities. We observed a significant 40%
(P < 10–4) decrease in the maximal M-cone b-wave amplitude in
Rlbp1–/– mice compared with that in both Rlbp1+/+ (control) and
Rlbp1+/– mice (Figure 1, A and B). In addition, we found a dramatic
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20-fold decrease in photopic sensitivity, as measured by the corresponding increase in I1/2 (the flash intensity required to achieve a
half-maximal response) of the Rlbp1–/– cone b-wave responses (Figure 1B). Surprisingly, light sensitivity in the absence of CRALBP
was diminished to such an extent that even the brightest light stimulus of the ERG system (697 cd × s/m2, Xenon flash) could not generate a saturated photopic b-wave response (Figure 1B, red circles).
In contrast, light sensitivity in Rlbp1+/– mice was comparable to that
in control mice (Figure 1B, blue triangles, inset).
In the course of these recordings, we noticed that the older
Rlbp1–/– mice had smaller cone b-wave amplitudes than did the
young adult mice. We compared the ERG b-wave responses from
6- to 7-week-old and 13- to 16-week-old mice to examine the
long-term effect of CRALBP knockout on mouse photopic vision.
In control animals, cone b-wave amplitude showed an approximately 10% (NS) reduction with age (Figure 1C). In contrast, the
cone b-wave amplitude of Rlbp1–/– mice decreased by nearly 50%
(P < 0.001) over the same 2-month period (Figure 1D). The light
sensitivity, as estimated from the I1/2 of the respective normalized
intensity-response curves, remained unchanged for both groups
within the 2 months of aging (Figure 1, C and D, insets). Thus, the
deletion of CRALBP caused a dramatic and progressive reduction
in cone-driven visual performance.
The deletion of CRALBP desensitizes mammalian cones and lowers
their phototransduction amplification. The reduced photopic b-wave
amplitude and sensitivity of CRALBP-deficient mice could be
caused by a deficit either in cone phototransduction or in cone-tobipolar cell synaptic transmission. To distinguish between the 2
possibilities, we determined whether cone phototransduction was
affected directly by the deletion of CRALBP by performing ex vivo
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Figure 2. Deletion of CRALBP reduces transretinal cone-response amplitude and sensitivity. (A) Representative transretinal cone responses from
control (left panel) and Rlbp1–/– (right panel) retinae. Test flash intensities
increased from 23 photons/μm2 to 1.40 × 106 photons/μm2 in steps of
0.5 log units. For both panels, the flash intensity producing the response
shown in red was 1.39 × 104 photons/μm2. (B) Ensemble-averaged absolute
and normalized (inset) cone intensity-response curves for control
(n = 13) and Rlbp1–/– (n = 13) retinae. (C) Ensemble-averaged normalized
cone dim flash responses from control (n = 12) and Rlbp1–/– (n = 13) retinae.
(D) Ensemble-averaged dim flash responses, r, from control (n = 13) and
Rlbp1–/– (n = 11) cones normalized to the maximal response, rmax, and to
flash intensity and with matched rising slopes to determine the change in
phototransduction amplification. Results are shown as the mean ± SEM.

recordings from isolated retina. This technique allowed us to pharmacologically block synaptic transmission (see Methods) and isolate the cone (a-wave) response. We used a 505-nm LED flash light
to stimulate the M-cones in these recordings. Similar to the in vivo
ERG b-wave results above, the ex vivo transretinal responses from
Rlbp1–/– cones were smaller than those from control cones, with a
greater than 50% (P < 0.05) decrease in maximal amplitude (Figure 2, A and B). Indicative of their reduced sensitivity, the responses
of Rlbp1–/– M-cones could not be saturated, even at the maximal
possible light intensity of our system (Figure 2B). The analysis of
their corresponding intensity-response functions showed a 20-fold
lower sensitivity (higher I1/2) compared with that in control cones
(Figure 2B, inset). The absence of CRALBP also resulted in a somewhat accelerated cone response inactivation (Figure 2C). In addition, consistent with their reduced light sensitivity, CRALBP-deficient cones had a 9-fold smaller phototransduction amplification
compared with that in control cones (Figure 2D), revealed by the
corresponding scaling factor required to match the rising slopes of
the fractional dim flash responses to 103 photons/μm2 for control
cones and 1,387 photons/μm2 for Rlbp1–/– cones. Taken together,
these results demonstrate that deletion of CRALBP in mice leads
to severe desensitization and altered cone phototransduction in
dark-adapted M-cones, which in turn produces a desensitized cone
b-wave and suppressed cone-mediated vision.
Deletion of CRALBP severely impairs mammalian cone dark adaptation. We next sought to determine the effect of CRALBP deletion
on RPE and retina visual cycles in the context of cone dark adaptation. First, we determined the overall effect of CRALBP deletion on

cone dark adaptation. Using in vivo ERG recordings, we examined
the cone b-wave sensitivity recovery of control and Rlbp1–/– mice
following exposure to a brief bright-green light estimated to photoactivate (bleach) 90% of the M-cone visual pigment (see Methods for details). As expected, cone b-wave sensitivity in the control mice underwent robust recovery following the bleaching and
returned within 50 minutes to an estimated 50% of the pre-bleaching level (Figure 3A, black squares). An incomplete photoreceptor
dark adaptation after bleaching, as detected in ERG recordings of
WT mice, is not unusual (6) and is most likely caused by the general
anesthetics (25). In striking contrast to the ERG response recovery
in control mice, M-cones in Rlbp1–/– mice recovered only a slight
fraction of their sensitivity following an identical bleaching (Figure
3A, red circles). Thus, cone dark adaptation in vivo, driven through
the combined action of the RPE and Müller cell visual cycles, was
severely compromised by the deletion of CRALBP. Notably, the
effect of CRALBP deletion on the recovery of cone sensitivity was
more pronounced than the previously reported delay in recovery of
cone b-wave–response amplitudes (22).
Next, to determine the specific effect of CRALBP deletion on
the Müller cell visual cycle, we performed cone dark-adaptation
experiments in retina dissected free of RPE, in which cone pigment regeneration can be driven only by the retinal visual cycle.
After an initial greater than 100-fold desensitization caused by
the bleaching, within seconds, cones in both control and Rlbp1–/–
retinae showed a rapid initial increase in sensitivity (Figure 3B).
This partial recovery, which was most likely due to inactivation
of the phototransduction cascade following the bleaching, was
comparable in the 2 mouse strains. However, the Rlbp1–/– cone
sensitivity failed to recover further during the 12 minutes of postbleach recordings, while control cones recovered to within 5-fold
of their pre-bleaching level (Figure 3B). We conclude that deletion of CRALBP has a dramatic effect on the ability of the retinal visual cycle to promote mouse cone dark adaptation. Taken
together, these results demonstrate that CRALBP plays a role
in both the RPE and retinal visual cycles and that its deletion
severely impairs the ability of both pathways to promote mammalian cone dark adaptation.
Dark rearing of CRALBP-deficient mice restores cone function
but not cone dark adaptation. It is believed that the role of CRALBP
in both the RPE and retinal visual cycles is to accelerate the production of 11-cis retinoid (1). We hypothesized that in the absence
of CRALBP, both visual cycles would still remain functional but
would fail to provide sufficient chromophore for sustaining normal
jci.org   Volume 125   Number 2   February 2015
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Figure 3. The deletion of CRALBP
suppresses cone dark adaptation. (A)
Normalized cone b-wave sensitivity (b-wave
Sf /b-wave SfDA) from in vivo ERG recordings
during dark adaptation following 90% pigment bleaching at t = 0 for control (n = 10)
and Rlbp1–/– (n = 10) mice. (B) Cone sensitivity, Sf, normalized to its dark-adapted value,
SfDA, from transretinal recordings during dark
adaptation following 90% pigment bleaching at t = 0 for control (n = 9) and Rlbp1–/–
(n = 10) isolated retinae. Results represent
the mean ± SEM.

cone function in 12-hour light/12-hour dark cyclic conditions. To
test this idea, we first attempted to restore cone function in Rlbp1–/–
mice by supplying them with exogenous chromophore in order to
regenerate any free cone opsin into visual pigment. However, the
application of either 9-cis retinal in vivo (Figure 4A) or 11-cis retinal ex vivo (Figure 4B) failed to rescue M-cone sensitivity. In contrast, treatment of chromophore-deficient Rpe65 –/– retinae with
exogenous 11-cis retinal ex vivo and application of 9-cis retinal to
Rpe65–/– mice in vivo resulted in a robust increase in rod sensitivity
and maximal response (data not shown), as previously reported
(26, 27). These results demonstrate that free opsin is not present

in Rlbp1–/– cones in detectable amounts and therefore is not the
cause for the reduced sensitivity and response amplitude of cones
in CRALBP-deficient mice.
We next examined whether the suppressed M-cone function
in CRALBP-knockout mice is caused by a long-term chromophore
deficiency. We raised Rlbp1–/– newborn mice in near-complete
darkness to substantially slow down the consumption of chromophore in their eyes and lower the demand for recycled chromophore by the cones. It was recently shown that raising mice
in complete darkness leads to an eventual decline in cone-tobipolar cell synaptic transmission (28). However, the occasional

Figure 4. Dark rearing, but not acute treatment with exogenous chromophore, rescues CRALBP-deficient cone sensitivity. (A) Normalized in vivo ERG
cone b-wave intensity-response curves for untreated control (replotted from Figure 2B inset) and 9-cis retinal–treated (n = 6) Rlbp1–/– mice. (B) Normalized transretinal cone intensity-response curves for control (black, n = 6) and Rlbp1–/– (red, n = 6) retinae in control solution (filled symbols; replotted
from Figure 3B inset) and after treatment with exogenous 11-cis retinal (open symbols, n = 6). 9cRal, 9-cis retinal; 11cRal, 11-cis retinal. (C) Cone b-wave
intensity-response curves from in vivo ERG recordings of control mice raised in cyclic light (black squares, n = 14) or in darkness (white squares, n = 10). (D)
Cone b-wave intensity-response curves from in vivo ERG recordings of control (black squares; replotted from Figure 1B) and Rlbp1–/– mice raised in cyclic
light (red filled circles; replotted from Figure 1B) and Rlbp1–/– mice raised in darkness (open red circles, n = 10). Insets in C and D show the corresponding
normalized intensity-response curves. (E) Normalized cone b-wave sensitivity (b-wave Sf / b-wave SfDA) from in vivo ERG recordings during dark adaptation
following 90% pigment bleaching at t = 0 for control (black squares) and Rlbp1–/– mice raised in cyclic light (filled red circles; replotted from Figure 4A) and
for Rlbp1–/– mice raised in darkness (open red circles, n = 10). Results represent the mean ± SEM.
730
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Figure 5. Deletion of CRALBP affects the localization of M-opsin and number of cones expressing M-opsin. Antibody staining of retinal frozen sections
from Rlbp1–/– and control mice for (A) M-opsin and (B) S-opsin. Representative images are shown. At least 3 retinae per condition were examined. Scale
bars: 25 μm. COS, cone outer segment; ONL, outer nuclear layer; OPL, outer plexiform layer. For clarity, the DAPI channel is not shown. (C) Quantification
of whole-mount M-opsin antibody staining (n = 4 retinae per condition). *P < 0.05, **P < 0.01 by unpaired 2-tailed Student’s t test. (D) Quantification of
whole-mount S-opsin antibody staining (n = 3 retinae per condition). D, dorsal; T, temporal; N, nasal; V, ventral. Young, 6- to 7-week-old mice; Old, 3- to
6-month-old mice. Results represent the mean ± SEM.

brief exposure to room light during routine animal care was
sufficient to maintain normal cone function in our control mice
and resulted in only a slight increase in the maximal amplitude
of their in vivo ERG b-wave response (Figure 4C). Importantly,
the photopic b-wave sensitivity of control mice, as measured from
their normalized intensity-response curve, was unchanged by the
dark rearing (Figure 4C, inset). In contrast, raising Rlbp1–/– mice
in darkness not only restored cone b-wave maximal response
(Figure 4D), but also boosted cone sensitivity levels to those of
control cones (Figure 4D, inset). However, a subsequent exposure to bleaching light unmasked the deficiency in cone pigment
regeneration, as the dark adaptation in CRALBP-deficient mice
was identical for animals raised in darkness and in cyclic light
(Figure 4E). Together, these results demonstrate that the dark
rearing of Rlbp1–/– mice slows down the consumption of chromo-

phore enough to preserve cone function. However, dark rearing
alone does not address the underlying deficit in the RPE and/or
retinal visual cycles.
Deletion of CRALBP induces M-opsin mislocalization and loss
of M-cones. What is the molecular mechanism underlying the
functional deterioration in CRALBP-deficient cones? Based on
the physiological results above, we hypothesized that CRALBP
was required for proper localization of opsin protein. To test this
hypothesis, we stained frozen sections from Rlbp1–/– and control
retinae with cone opsin antibodies. Whereas M-opsin was localized to the cone outer segment of the control retinae as expected,
we observed striking mislocalization of M-opsin to the cone cell
bodies, axons, and pedicles of young (6-week-old) and old (4to 6-month-old) Rlbp1–/– mice raised conventionally in cyclic
light-dark conditions. Intriguingly, dark rearing of Rlbp1–/– mice
jci.org   Volume 125   Number 2   February 2015
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Figure 6. AAV-mediated delivery of CRALBP to Müller cells or RPE cells. Antibody staining shows expression pattern of CRALBP in (A) control retina, (B)
Rlbp1–/– retina, (C) Müller cells of Rlbp1–/– retina after intravitreal injection with an AAV construct targeted for Müller cells shH10-scCAG-RLBP1, and (D) RPE
of Rlbp1–/– retina after intravitreal injection with an AAV construct targeted for RPE 7m8-scVMD2-RLBP1. Scale bars: 50 μm. INL, inner nuclear layer; GCL,
ganglion cell layer. Widespread infection across the retina was achieved for both constructs, as seen in tiled images for (E) shH10-scCAG-RLBP1 and (F)
7m8-scVMD2-RLBP1. Red channel, anti-CRALBP; blue channel, DAPI. Scale bar: 200 μm.

appeared to ameliorate M-opsin mislocalization to some extent
(Figure 5A), consistent with the physiology results above. In contrast to M-opsin, S-opsin was appropriately localized to the cone
outer segments in the retinae of both Rlbp1–/– and control mice (Figure 5B). We also wondered whether the M-opsin mislocalization
in Rlbp1–/– retinae was correlated with M-cone numbers. Quantification of whole-mount antibody staining revealed a lower density of M-opsin–expressing cones in the dorsal retinae of Rlbp1–/–
mice compared with dorsal retinae in age-matched controls (Figure 5C), whereas the density of S-opsin–expressing cones was not
affected (Figure 5D). Thus, the deletion of CRALBP resulted in
both mislocalization of M-opsin and M-cone loss. However, overall, the cone density in Rlbp1–/– retinae did not change markedly
with age, suggesting that the observed age-dependent decline in
cone function was caused by progressive deterioration in the light
responses of individual M-cones.
The retinal visual cycle is essential for cone function. In the above
results, we demonstrated that CRALBP was crucial for maintaining normal M-cone function in a cyclic light environment and for
proper cone dark adaptation. However, because in these experiments CRALBP was absent in both RPE and Müller cells, we were
not able to determine the relative contribution of each visual cycle
to maintaining normal cone function. To address this question,
we used 2 separate AAV vectors to express CRALBP specifically
in either RPE or Müller cells of adult Rlbp1–/– mice (see Methods
for details). First, we verified that CRALBP was delivered via intravitreal AAV injection to the RPE (via the RPE-specific AAV construct 7m8-scVMD2-RLBP1) or to the Müller cells (via the Müller
cell-specific AAV construct shH10-scCAG-RLBP1) in Rlbp1–/– retinae. As previously shown (22), antibody staining revealed robust
CRALBP expression in the RPE and Müller cells of WT mice
(Figure 6A) and its complete absence in Rlbp1–/– eyes (Figure 6B).
Notably, immunohistochemistry revealed expression of CRALBP
732
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specifically in the targeted cell type for both AAV constructs (Figure 6, C and D). Moreover, the extent of intravitreal AAV infection appeared to be widespread, as demonstrated by the CRALBP
expression in the targeted cell type along the length of the retina
(Figure 6, E and F).
We then examined how the rescue of each visual cycle affected
the dark-adapted function of M-cones as well as their ability to
recover light sensitivity rapidly following a bleaching. The transretinal recordings revealed that dark-adapted cone sensitivity in
Müller cell CRALBP–expressing Rlbp1–/– mice was improved by
approximately 10-fold (Figure 7A) and that amplification of cone
phototransduction was enhanced by 5.8-fold compared with controls (Figure 7B). In contrast, dark-adapted cone responses from
RPE cell CRALBP–expressing Rlbp1–/– mice were indistinguishable
from those of their AAV-GFP–injected littermates (Figure 7, A and
B). This result demonstrates that expression of CRALBP in Müller
cells is required for the normal function of dark-adapted M-cones.
The dim flash–response kinetics, cone maximal response, and
cone b-wave maximal response were not affected by either RPE
or Müller cell expression of CRALBP (data not shown), indicating
an incomplete rescue of cone function. We also note that AAVmediated CRALBP delivery to either RPE or Müller cells failed
to correct the M-opsin mislocalization defect (data not shown).
Notably, in vivo cone dark adaptation was markedly improved
by the AAV-mediated CRALBP rescue of either visual cycle with
indistinguishable time courses (Figure 7C). In contrast, only the
expression of CRALBP in Müller cells resulted in the rescue of
cone dark adaptation in the isolated RPE-free retina, whereas
expression of CRALBP in RPE had no effect on cone dark adaptation under these conditions (Figure 7D). Together, these results
demonstrate the role of the retinal visual cycle in supporting mammalian M-cone function and indicate that CRALBP in Müller cells
plays a key role in this pathway.
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Figure 7. AAV-driven expression of CRALBP in
Müller cells rescues the sensitivity and dark adaptation of CRALBP-deficient cones. (A) Ensemble-averaged transretinal cone intensity-response curves for
Rlbp1–/– mice injected with AAV driving expression of
GFP in RPE or Müller cells (black squares, n = 4),
CRALBP in Müller cells (red circles, n = 5), and
CRALBP in RPE cells (green diamonds, n = 3). (B)
Transretinal dim flash responses of Rlbp1–/– mice
showing the relative amplification for AAV-driven
control GFP (black, n = 4), Müller cell–specific
CRALBP (red, n = 5), and RPE-specific CRALBP
(green, n = 3) expression. (C) In vivo ERG recordings
of cone b-wave dark adaptation (b-wave Sf/b-wave
SfDA) after a 90% bleaching in Rlbp1–/– mice with AAVdriven expression of control GFP (black, n = 11), Müller
cell–specific CRALBP (red, n = 12), and RPE-specific
CRALBP (green, n = 8). (D) Transretinal recordings of
cone dark adaptation (Sf/SfDA) after a 90% bleaching
of Rlbp1–/– retinae with AAV-driven expression of control GFP (black, n = 4), Müller cell–specific CRALBP
(red, n = 5), and RPE-specific CRALBP (green, n = 3).
Results represent the mean ± SEM.

Deletion of CRALBP affects the pupillary light reflex. Besides
rods and cones, another cell type in the retina that requires chromophore for its function is the intrinsically photosensitive retinal
ganglion cell (ipRGC) (29). CRALBP in Müller cells was recently
proposed to facilitate the supply of 11-cis retinal to ipRGCs
(30). We investigated this possibility by evaluating the effect of
CRALBP deletion on light-driven pupil constriction. Rods in both
control and Rlbp1–/– mice do not respond to light due to the absence
of GNAT1, and their pupillary light reflex is therefore mediated by
the 2 remaining light-sensitive cell types in the retina: cones and
ipRGCs (31). In melanopsin-knockout animals that lack melanopsin phototransduction but maintain normal cone function, there
is a clear reduction in the magnitude of the pupillary light reflex,
but only at high light intensities (32). To determine whether melanopsin phototransduction is affected in Rlbp1–/– mice, we exposed
1 eye to light and measured pupil constriction in the contralateral
eye (Figure 8A). This enabled us to evaluate the overall sensitivity
of the pupillary light reflex. Two-way ANOVA analysis showed an
overall significant difference (P < 0.001) between the pupil constriction intensity-response curves of control and Rlbp1–/– mice.
Further 1-way ANOVA statistical analysis followed by Bonferroni’s
correction on the P values at each intensity revealed a significantly
higher (P < 0.05) threshold for pupil constriction in Rlbp1–/– mice
compared with that in controls (Figure 8B). The light intensity
required to reach 50% effective constriction (EC50) was also
slightly higher in CRALBP-deficient mice compared with that in
controls, but the difference was not statistically significant (Figure
8C). The maximal pupil constriction in bright light of Rlbp1–/– mice
was comparable to that of controls, suggesting that the function
of ipRGCs is largely unaffected by the deletion of CRALBP (32).
In contrast, the maximal pupillary light reflex of Rpe65 –/– mice,
in which all photoreceptor function is severely suppressed due to

a lack of chromophore (33), was dramatically reduced (Figure 8,
A and B). This analysis suggests that the pupillary light reflex is
overall different in Rlbp1–/– mice, with the difference restricted to
relatively dim light levels, in which the pupil response is primarily driven by cone signals. The response at higher light intensities,
which is dominated by the ipRGC signals, was not affected by the
deletion of CRALBP. Together, these results indicate that CRALBP
is not required for the delivery of chromophore to ipRGCs or for
the regeneration of melanopsin and that the decreased sensitivity
of the pupillary light reflex in Rlbp1–/– mice is most likely caused by
suppressed cone function. However, a conclusive determination
of this issue would require the generation of triple-knockout animals that lack both rod and cone phototransduction pathways in
addition to a lack of the Rlbp1 gene.

Discussion

Molecular evidence for the function of a mammalian retinal visual
cycle. The idea of a second, cone-specific visual cycle was first
put forth in the 1970s (34) and has been gaining acceptance and
experimental support in recent years (3, 4, 35). This pathway
was proposed to involve the conversion of spent all-trans retinol,
released from cones, back into 11-cis retinol in the retinal Müller
cells (3). Indeed, it was shown recently that the retina promotes
pigment regeneration and dark adaptation in cones independently
of the RPE, and that pharmacological ablation of Müller cells
blocks this process (5). Recent biochemical studies have identified
putative retinoid isomerase (7) and ester synthase activities (8) in
Müller cells consistent with a retinal visual cycle. However, the
molecular mechanism involved in the trafficking and recycling of
chromophore still remains largely unknown, and skepticism still
remains, partly due to the lack of experimental evidence for the
involvement of any of the putative molecular players in this pathjci.org   Volume 125   Number 2   February 2015
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(Figures 1 and 2). Notably, this suppressed cone function can be rescued
by raising the animals in darkness
(Figure 4). This result indicates that
unlike the other widely studied chromophore-binding protein IRBP (39,
40), CRALBP is not required for the
normal development and survival of
cones. Instead, the preservation of
normal cone function in dark-reared
Rlbp1–/– mice suggests that the cone
phenotype is caused by inadequate
chromophore supply. One possibility
is that the delayed recycling of chroFigure 8. Deletion of CRALBP reduces the threshold of the pupillary light reflex. (A) Comparison of pupil
size in darkness and in the light (~14 log photons/cm2/s) in control, Rlbp1–/–, and Rpe65–/– (Gnat1+/+) negative
mophore in the absence of CRALBP
control mice. (B) Averaged intensity-response curves for control (n = 5), Rlbp1–/– (n = 5), and Rpe65–/– (n = 4)
leads to chronic chromophore defimice. A significant difference was observed at threshold (*P < 0.05) between Rlbp1–/– and control mice by
ciency, so that even after overnight
2-way ANOVA followed by Bonferroni’s post test. Results represent the mean ± SEM. (C) Intensity required
dark adaptation of these mice, the
–/–
to reach EC50 in control and Rlbp1 mice. P = 0.10, NS, by 2-tailed unpaired Student’s t test.
pigment content of their cones is still
not fully restored. However, considering that CRALBP-deficient rod responses are normal after 18
way in actually controlling the function of cones. Here, we settle
hours of dark adaptation (22), it is unlikely that only cones would
this question by demonstrating that the deletion of CRALBP in
be affected by such incomplete dark adaptation. Indeed, our
Müller cells prevents this pathway from promoting dark adaptaobservation that application of exogenous chromophore failed to
tion in mouse cones. Our results also reveal a previously unapprerescue cone function (Figure 4) rules out this possibility.
ciated role of the retinal visual cycle in the long-term maintenance
An alternative hypothesis is that the chronic deficiency of chroof normal mammalian cone function.
mophore affects cone opsin levels. Evidence for this notion comes
The role of CRALBP in the retinal visual cycle. We found that
from studies of a key enzyme in the RPE visual cycle, RPE65. In
deletion of CRALBP in mice resulted in a dramatic suppression
contrast to the slowed-down RPE visual cycle in Rlbp1–/– mice,
of cone dark adaptation both in vivo, when driven by the combined action of the RPE and retinal visual cycles (Figure 3A),
Rpe65–/– mice lack this pathway completely and are unable to supand ex vivo, when driven only by the retinal visual cycle (Figure
ply chromophore to their photoreceptors (41). This results in mis3B). Therefore, suppression of the RPE visual cycle by deletion of
localization of cone opsin and very rapid degeneration of the cones
CRALBP not only affects the rods, as previously shown by Saari et
(42, 43), both of which are attributed to chromophore deficiency
al. (22), but also compromises the ability of the RPE to drive the
(42, 44). Consistent with the role of chromophore in supporting
dark adaptation of cones. More important, our results also clearly
cone opsin folding and expression, a recent study demonstrated
demonstrate that CRALBP in Müller cells plays a similar role in
that proper cone opsin expression requires sufficient chromophore
the retinal visual cycle to promote cone dark adaptation.
supply to the endoplasmic reticulum (45). In addition, 11-cis retWhat is the mechanism of CRALBP function in the retinal
inal in the inner segment of cones also appears to facilitate the
visual cycle? The rescue of cone function in dark-reared Rlbp1–/–
transport of several phototransduction proteins to the cone outer
segments (46). Thus, the deterioration of M-cone function that
mice indicates that deletion of CRALBP does not block the funcwe observed in Rlbp1–/– mice is likely a direct result of the chromotion of the retinal visual cycle; rather, CRALBP likely regulates
its efficiency or kinetics. In RPE, CRALBP interacts with the
phore deficiency caused by impairment of the retinal visual cycle.
isomerohydrolase to carry 11-cis retinol and facilitate its oxidation
Notably, we found that S-cone opsin localization and expression
to 11-cis retinal (36). A recent study suggests that in vitro CRALBP
were not affected in Rlbp1–/– mice (Figure 5, B and D), indicating
closely interacts with DES1, the proposed retinoid isomerase in
that apo S-opsin might be more stable than its M-opsin counterMüller cells (7). Therefore, it is possible that CRALBP takes up
part. It is intriguing in this context that mouse M-cones are more
11-cis retinol from DES1 and facilitates the reisomerization of
susceptible to age-dependent degeneration than are S-cones (47),
chromophore by the retinal visual cycle. CRALBP also facilitates
suggesting that cone opsin stability might play a role in age-depenthe release of chromophore from RPE cells and its subsequent
dent cone degeneration. Regardless of the mechanism affecting
uptake by photoreceptors (37, 38). Thus, a second possibility is
the loss of cone function in Rlbp1–/– mice, the rescued cone functhat CRALBP plays a similar role in Müller cells and accelerates
tion in animals raised in darkness suggests that minimizing light
the flow of chromophore to cones.
exposure might be a simple and effective approach for protecting
The influence of chromophore deficiency on cone function. Rods
cones from degeneration and preventing photopic vision loss in
in CRALBP-deficient mice have normal sensitivity and maximal
patients with CRALBP-based visual disorders.
response after overnight dark adaptation (22). In striking conThe contribution of 2 visual cycles to cone function. By selectrast, dark-adapted cones in CRALBP-deficient mice have signifitively rescuing either the RPE or Müller cell visual cycle using
cantly reduced response amplitude and 20-fold lower sensitivity
AAV-RLBP1 in Rlbp1–/– mice, we were able to identify the contribu734
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tion of each visual cycle to supporting normal cone sensitivity and
dark adaptation. Our finding that only rescue of the retinal visual
cycle, but not the RPE visual cycle, restores normal sensitivity of
dark-adapted Rlbp1–/– cones (Figure 7) reveals a previously unappreciated function of the retinal visual cycle and demonstrates
that this pathway plays a crucial role in maintaining long-term
cone function. One interesting unexplored possibility emerging
from these results is that age-dependent decline in the efficiency
of the Müller cell visual cycle contributes to the gradual loss of
cone function and is linked to age-related cone visual disorders
in patients. Thus, genetic or pharmacological treatments aimed
at boosting the retinal visual cycle might have therapeutic benefit
for age-dependent cone visual loss.
It has been suggested that cone dark adaptation is biphasic,
with an initial fast recovery dominated by the retinal visual cycle
and a slow subsequent recovery contributed by the RPE visual
cycle (6). However, we found that the rescue of either of the 2
visual cycles in Rlbp1–/– mice results in cone dark adaptation in vivo
with indistinguishable kinetics (Figure 7C). It is not clear at the
moment whether this reflects a more complex interplay between
the contributions of the 2 visual cycles than was previously appreciated, or a developmental compensatory modulation of 1 pathway in the absence of the other. Interestingly, neither of the rescues of the 2 visual cycles restored the maximal cone response,
suggesting reduced cone number or phototransduction capacity.
One possibility is that both visual cycles are required for normal
cone function. Alternatively, it is possible that the loss of cone
function in Rlbp1–/– mice is caused by chromophore deficiency at
an early stage of development and therefore could not be rescued
by AAV injections in adult animals. While the 2 hypotheses are not
mutually exclusive, our aging experiments on Rlbp1–/– mice (Figure
1) support the latter. Future studies with animals of different ages
should resolve these questions and provide invaluable information about the therapeutic potential of such treatments. Notably,
we were able to achieve selective and highly efficient CRALBP
expression in Müller cells and even in the RPE (Figure 6F) with an
intravitreal AAV injection.

Methods

Animals. CRALBP-deficient mice (22) were provided by John Saari
(University of Washington, Seattle, Washington, USA). To facilitate
cone recordings, CRALBP-knockout mice were crossed with rod
transducin α–knockout mice (Gnat1–/–) (23) obtained from Janis Lem
(Tufts University, Boston, Massachusetts, USA) to eliminate rod
responses. The role of CRALBP in cone function and morphology was
then determined by comparing adult (6 weeks to 6 months of age)
control (Gnat1–/–) and Rlbp1–/– (CRALBP-deficient Gnat1–/–) mice. All
mice used in this study were confirmed to be free of the rd8 mutation
(48). For dark-rearing experiments, newborn mice were transferred to
a light-proof cabinet and briefly exposed to ambient light only once
a week during cage changing. All other mice were raised in a 60 Lux
12-hour light/12-hour dark cycle. Animals were dark adapted for 18
hours before electrophysiological recordings and at least 30 minutes
prior to pupillary light reflex tests. The animals used for the optomotry
tests were light adapted before the experiment. In addition, Rpe65 –/–
(Gnat1+/+) mice were used as control animals for pupillary light reflex
and exogenous chromophore treatment experiments.

Research article

Photopic vision measured from optomotor responses. The threshold
of contrast sensitivity was measured with a commercially available
OptoMotry System (CerebralMechanics) as previously described (6).
The intensity of the background light of the system was controlled with
a custom-made cylinder of neutral-density filter film, wrapped around
the mouse stand. The contrast-sensitivity threshold at a 0.128 cycles/
degree grating spatial frequency was measured by an automated computer program when mice failed to provide optomotor responses. The
tests started from brightest (1.84 log cd × s/m2) to dimmest (–3.56
log cd × s/m2) background light intensity. Intriguingly, we observed
that 2 of the tested CRALBP-deficient Gnat1–/– mice (Rlbp1–/–) did not
respond normally to the moving bar in the test and instead rotated
their head in the direction opposite to the moving bar. Therefore, we
excluded the results from these 2 mice from our analysis.
Electrophysiology. In vivo ERG recordings were performed
with a commercial LKC system (LKC Technologies) as previously
described (6). The dark-adapted animals were anesthetized with
ketamine (100 mg/kg) and xylazine (20 mg/kg), and their pupils
were dilated with atropine sulfate eye drops. A mouse was placed
onto a 37°C heating pad, and electrodes were connected to its cornea to amplify electrical signals generated by the retina. A reference
electrode was connected to beneath the skin at the scalp between
the eyes. The animal was allowed to stabilize in darkness for 15 minutes before the recordings were started. Test flashes of increasing
intensity (530-nm LED up to a 25 cd × s/m2 limit and white Xenon
flash for higher intensities) were delivered by the Ganzfeld sphere,
and the ERG signals were recorded to obtain the intensity-response
curves. To test the dark-adaptation kinetics, bright-green LED light
(520 nm) was used to bleach an estimated 90% of the photopigments in 30 seconds. Then the cone sensitivity was recorded at preset time intervals until 52 minutes after photobleaching. The cone
b-wave flash sensitivity was normalized to the pre-bleaching value
to determine the sensitivity recovery curve. For exogenous chromophore application experiments, 300 μg 9-cis retinal was dissolved in
200 μl NaCl/BSA solution (with 10% ethanol) and administered by
i.p. injection. The treated animals were dark adapted overnight prior
to in vivo ERG recordings.
Transretinal recordings were performed with isolated mouse retina as previously described (49, 50). The isolated retina was carefully
mounted on a custom-made chamber for transretinal voltage recordings (51). The retina was perfused with Locke’s solution bubbled with
O2 and CO2 and supplemented with 30 μM DL-AP4 to block synaptic
transmission. After setting up the recording chamber, the retina was
allowed to stabilize for 15 minutes before any recording was done. The
responses of cones to 1-ms-long 505-nm LED-generated test flashes of
various intensities were amplified and recorded on a desktop computer
with pClamp 10 software (Molecular Dynamics). Dim flash analysis was
performed with amplitude responses below 30% of the maximal amplitude for each retina (52). For dark-adaptation tests, preprogrammed
protocols were used to precisely monitor the fast recovery of cone
sensitivity during the first 12 minutes following an estimated 90%
photobleaching of the visual pigments. The cone sensitivity was normalized to the pre-bleaching level to generate the sensitivity recovery
curve. For exogenous chromophore application experiments, 300 μg
11-cis retinal was dissolved in 4 ml 0.01% ethanol Locke’s solution,
and an isolated retina was incubated with 0.5 to 1 ml of that solution
for 1 hour in darkness. Cone responses from the treated retinae were
jci.org   Volume 125   Number 2   February 2015
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then obtained using transretinal recordings. For all recordings, the sensitivity, Sf , was estimated from the ratio of the amplitude, r, of a flash
response from the linear range (<30% of the saturated response, rmax)
and the corresponding flash intensity.
Frozen sections. Eyes were fixed in 4% paraformaldehyde in PBS
for 2 hours at room temperature, rinsed with PBS, and then cryoprotected in 30% sucrose. The lens was removed prior to embedding
in Tissue-Tek OCT compound (Sakura). Frozen blocks were cryosectioned at a thickness of 12 to 14 μm. For immunohistochemical
staining, sections were blocked for approximately 1 hour at room
temperature, followed by overnight incubation at 4°C with primary
antibody, except for anti-CRALBP, which was incubated for 2 hours
at room temperature. The following primary antibodies were used:
rabbit anti–red/green cone opsin (AB5405; EMD Millipore) at 1:600;
rabbit anti–blue cone opsin (AB5407; EMD Millipore) at 1:200; and
rabbit anti-CRALBP (UW55 polyclonal antibody isolated from rabbits immunized with human recombinant CRALBP; a gift of John
Saari, University of Washington; refs. 22, 53) at 1:200. The following
fluorescently labeled secondary antibodies were used, respectively:
Alexa Fluor 555 donkey anti-rabbit (A-31572; Molecular Probes) at
1:800; Alexa Fluor 488 donkey anti-rabbit (A-21206; Molecular
Probes) at 1:500; and Alexa Fluor 555 donkey anti-rabbit (A-31572;
Molecular Probes) at 1:800. Secondary antibodies were applied for
30 minutes at room temperature, followed by DAPI staining, application of VECTASHIELD (Vector Labs), and coverslipping. The
following blocking solutions were used: 0.1% Triton X-100 and 5%
normal donkey serum in PBS for staining of opsins, and 0.5% Triton
X-100 and 2% normal donkey serum in PBS for staining of CRALBP.
Primary and secondary antibodies were diluted in blocking solution. Slides were stored at –20°C until imaging. Images were taken
as multi-plane captures using an Olympus BX61WI microscope and
a Hamamatsu ORCA-AG CCD camera and processed with MetaMorph software (Molecular Devices) and Adobe Photoshop, except
for Figure 6, E and F, which were taken as single-plane captures
using an Olympus BX51 microscope and an Olympus DP70 camera
and processed with SlideBook software (Intelligent Imaging Innovations) and Adobe Photoshop.
Whole-mount immunostaining. Retinae were dissected in PBS
with the lens intact, fixed for 30 minutes at room temperature with
4% paraformaldehyde in PBS, and rinsed with PBS prior to removal of
the lens. Retinae were blocked for approximately 1 hour at room temperature, followed by overnight incubation at 4°C with the primary
antibody. The following primary antibodies were used: rabbit anti–
red/green cone opsin (AB5405; EMD Millipore) at 1:500 and goat
anti–blue opsin (sc-14363; Santa Cruz Biotechnology Inc.) at 1:500.
The following fluorescently labeled secondary antibodies were used,
respectively: Alexa Fluor 555 donkey anti-rabbit (A-21206; Molecular Probes) at 1:800 and Alexa Fluor 488 donkey anti-goat (A-11055;
Molecular Probes) at 1:800. Secondary antibodies were applied for
30 minutes at room temperature. A blocking solution consisting of
0.5% Triton X-100 and 2% normal donkey serum in PBS was used.
Primary and secondary antibodies were diluted in blocking solution.
Retinae were stored light-protected in PBS at 4°C until imaging,
whereupon they were whole mounted with glass shards at the corners of the slide and coverslipped.
Cone quantification. Whole-mounted retinae were imaged as single-plane captures using a ×10 objective lens with an Olympus BX51
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microscope and an Olympus DP70 camera. Image files were annotated in Adobe Photoshop with dots to mark opsin staining. The dots
were quantified using the “Analyze Particles” feature in ImageJ software (NIH). Quantification was conducted in 170 μm × 170 μm fields
located in the dorsal, nasal, temporal, and ventral quadrants.
AAV vector preparation and injection. Four types of AAV vectors were used for the injection: shH10-scCAG-RLBP1 (expressing
CRALBP in Müller cells, Müller-CRALBP); 7m8-scVMD2-RLBP1
(expressing CRALBP in RPE cells, RPE-CRALBP); shH10-scCAG-GFP
(expressing GFP in Müller cells, GFP control); and 7m8-scVMD2-GFP
(expressing GFP in RPE cells, GFP control). The Müller glia–specific
viruses (shH10-scCAG-RLBP1/GFP) were constructed using a Müller
glia–specific AAV serotype shH10 and the ubiquitous synthetic CAG
promoter (54). The RPE-specific viruses (7m8-scVMD2-RLBP1/GFP)
were built using a pan-retinally expressing AAV serotype 7m8 and the
RPE-specific promoter VMD2 (55, 56). To generate the scCAG-RLBP1
viral transfer plasmid, RLBP1 was reverse transcribed from purified
WT mouse retina total mRNA. Then the GFP ORF of a self-complementary AAV vector expressing GFP under CAG promoter control
was replaced with the Rlbp1 cDNA using restriction enzymes. This
plasmid was then further processed to generate the scVMD2-RLBP1
transfer plasmid through replacement of the CAG promoter with the
PCR-purified VMD2 promoter. The control scCAG-GFP and scVMD2-GFP viral plasmids were created using the same process without
the replacement of the GFP ORF. For the generation of each virus,
293T cells at 80% confluence were cotransfected with the appropriate transfer plasmid, pHelper plasmid, and the AAV rep/cap plasmid
(shH10 or 7m8) at a molar ratio of 1:1:1. At 72 hours after transfection,
cells were collected, pelleted, resuspended in lysis buffer, freezethawed, and then treated with Benzonase. Cell debris was removed by
centrifugation, and the supernatant was loaded onto an iodixanol gradient and subjected to ultracentrifugation. The 40% virus–containing
iodixanol fraction was removed from the gradient, and the iodixanol
was replaced via buffer exchange using Amicon Ultra-15 Centrifugal
units in PBS. Titers were determined by quantitative PCR relative to
a standard curve (57). An aliquot of 1 to 1.5 μl of the virus was injected
into the vitreous of anesthetized 4-week-old mice using a Hamilton
syringe. Animals were harvested 4–5 weeks after the injection for cone
electrophysiology experiments and 8 weeks after the injection for
immunohistochemistry.
Pupillary light reflex. All mice were awake and manually restrained
while a 480-nm LED light was directed to 1 eye (the left eye). The light
stimulus lasted for 30 seconds, after which the mouse was returned to
its cage to dark adapt until the next light stimulus. Individual frames of
the movie were taken from VLC Media Player. The images were analyzed in ImageJ. A comparison was made of the pupil area in darkness
and after 30 seconds of light exposure to generate a ratio. For doseresponse curves, the data were fitted with a variable-slope sigmoidal
dose-response curve, with the top constrained to 1.0 and the bottom
constrained between 0 and 0.1.
Statistics. Unless otherwise noted, a 2-tailed unpaired Student’s
t test was used to test for the significance of differences in the mean
values of 2 sample groups. A P value of less than 0.05 was considered
statistically significant.
Study approval. The care, maintenance, and treatment of the animals in this study followed protocols approved by the Washington
University Animal Studies Committee.
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